Загрузка...
Drug-conjugated antibodies for the treatment of cancer
Despite considerable effort, application of monoclonal antibody technology has had only modest success in improving treatment outcomes in patients with solid tumours. Enhancing the cancer cell-killing activity of antibodies through conjugation to highly potent cytotoxic ‘payloads’ to create antibody...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Science Inc
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3731599/ https://ncbi.nlm.nih.gov/pubmed/23173552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12044 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|